"Now, basically, everyone's coming to the middle and asking, 'How do we responsibly cover these drugs?'" Part of responsible coverage, Inkinen said, is providing other forms of support to patients who stop using GLP-1 medications, by choice or otherwise
Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment
On average, people taking injectable Semaglutide with Henry lost ~18% of their body weight in a year.1 Everyone is different and your results will vary depending on your medication, dosing, medical history, and other factors like diet and exercise
Wang Y, et al
its a combination of things that work together to activate your bodys natural reparative ability
patients and clinicians should refer to the primary trial publication for specific figures, as these data are dose-dependent and subject to ongoing analysis